Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820555 · ClinicalTrials.gov registry record · NA
The Goodnight Screen Media Study
A NA study of Sleep and Sleep Hygiene, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05820555: Recruiting NA study of Sleep and Sleep Hygiene, sponsored by Baylor College of Medicine.
NCT05820555 is a NA study of Sleep and Sleep Hygiene that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 180 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05820555, a NA study of Sleep and Sleep Hygiene, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
To test the timing of evening tablet use on children's circadian phase and sleep (i.e., sleep onset and sleep duration) compared to no screen media use. To explore the effect of evening tablet use on children's inhibitory control and executive function.
Primary Outcome
Circadian phase can be examined by measuring the circadian timing of melatonin onset under dim light conditions (dim light melatonin onset; DMLO). Compared to markers of endogenous circadian rhythms, melatonin is relatively robust. Salivary DLMO measures have demonstrated high intraclass correlations (.93) with plasma and sensitivity and specificity comparable to plasma assays. Following established procedures with children, salivary DLMO will be collected on a in the laboratory under dim light
Conditions Studied
Interventions
- BEHAVIORAL Timed evening technology and digital media use (tablet use)
- BEHAVIORAL no technology and digital media use (screen media use)
Study Locations (1)
Texas
- Children's Nutrition Research Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05820555 shows while recruiting
NCT05820555 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Timed evening technology and digital media use (tablet use) is the first listed.
NCT05820555 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05820555 about?
NCT05820555 is a clinical study titled "The Goodnight Screen Media Study". To test the timing of evening tablet use on children's circadian phase and sleep (i.e., sleep onset and sleep duration) compared to no screen media use. To explore the effect of evening tablet use on children's inhibitory control and executive function.
What is the current status of trial NCT05820555?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-04-24. Estimated completion is 2026-08-31.
What conditions does trial NCT05820555 study?
This clinical trial studies the following conditions: Sleep, Sleep Hygiene.
What interventions are being tested in trial NCT05820555?
The interventions under investigation include: Timed evening technology and digital media use (tablet use) (BEHAVIORAL), no technology and digital media use (screen media use) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05820555?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05820555 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05820555's enrollment target sits among peer trials
180 34th of 151 higher than 116 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
-
The Effects on Sleep Quality of 1:4 Reishi Liquid Extract
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI